MVMT™ ( Measurable Variance Minimal Term ) was developed to fill a critical gap in adherence measurement: the lack of a behaviorally anchored, time-specific instrument that captures a patient’s actual medication-taking behavior over a defined recent period. Existing scales often rely on present-tense, perception-based items, which can introduce recall bias, optimism bias, and psychometric inconsistencies. MVMT addresses these limitations by focusing on concrete behavior over the past week, providing a precise “snapshot” of adherence.
Where BASE™ measures predictive stability—the “video” of where a patient is heading—MVMT™ captures retrospective reality, the “still photograph” of what has already occurred. Together, these tools form a dual-lens system that grounds adherence assessment in both predictive modeling and lived behavioral evidence.
Behavioral science shows that past behavior is the best predictor of future behavior. To ensure validity, MVMT items are:
This is not a test. There are no right or wrong answers. Everyone manages medications differently. These assessments are designed to understand patient experiences, identify patterns, and guide supportive care. Responses are confidential.
Scoring for each item:
Answer each question as honestly as possible, reflecting your recent experiences.
Intentional Non-Adherence Items: Q3 (Symptom Response) and Q4 (Side-Effects Response)
MVMT_norm Raw Score (0–7) Descriptor Interpretation
0.00–0.25 0–1.75 Highly Prone Adherence very limited
0.26–0.50 2–3.5 Unstable Multiple lapses, inconsistent behavior
0.51–0.75 3.5–5.25 Moderately Steady Mostly adherent, occasional lapses
0.76–1.00 5.25–7 Reliable Strong adherence, few or no lapses
MVMT provides a concrete behavioral snapshot, capturing real-time adherence and enabling the calculation of behavioral fragility metrics in conjunction with BASE and STRATA. By distinguishing between intentional and unintentional lapses, the instrument provides actionable insights for clinicians, supporting tailored interventions.
Analogy:
MVMT™ is the intellectual property of Philip Morisky and is exclusively distributed through Adherence Cartography. Unauthorized use, reproduction, or distribution is strictly prohibited.
Disclaimer on Use of the BSA Instrument
The BSA (Behavioral Stability Assessment) is an exploratory, hypothesis-generating research instrument. It is currently not a validated clinical tool and should not be used as the sole basis for diagnosis, treatment decisions, or patient care planning.
Preliminary findings have provided favorable insights into its potential utility, but further validation studies are required to establish its reliability, validity, and clinical applicability. Any use of the BSA at this stage should be considered investigational and for research purposes only.
Copyright © 2023 Adherence. All Rights Reserved.
Adherence Cartography™, Behavioral Stability Assessment (BSA™,), Behavioral Adherence Score (BAS™), and Behavioral Stability Index (BSI™) are trademarks of Adherence Cartography.
MMAS®, MMAS-4™, MMAS-8™, Morisky Medication Adherence Scale™, and Morisky Scale™ are registered trademarks or trademarks owned by Dr. Donald E. Morisky.
health tech, digital health, telehealth, healthcare innovation, medical technology, ehealth, health informatics, remote patient monitoring, mhealth, telemedicine, patient engagement, wearable health devices, health app, ai in healthcare, telehealth solutions, virtual care, health tech startups, connected health, population health management, healthcare analytics, personalized medicine
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Join us in advancing a national movement toward cartographic behavioral science and precision-guided adherence care.
Your support helps bring the BASE™, MVMT™, and STRATA™ frameworks to Bhutan’s health system in partnership with the Ministry of Health. Together, we are building the foundation for a behaviorally intelligent health infrastructure, equipping clinicians and policymakers to map, measure, and strengthen real-world treatment stability.
Your contribution directly advances evidence-based care, empowering Bhutan to lead in the next generation of global adherence innovation.
[Donate Now]